Question

At a pharmaceutical firm, researchers are assigned to clusters of diseases (mental health conditions, autoimmune diseases, neurological diseases) rather than to a specific drug research project. What might be some of the benefits of organizing the firm’s research efforts in this manner?

Answer 1

Solution: Pharmaceutical firms face lot of challenges from stringent regulatory compliances and enormous R&D cost. Assigning clusters of diseases (mental health conditions, autoimmune diseases, neurological diseases) to researchers rather than to a specific drug research project can improvise communication between internal functional departments and identify synergies in their operations. This could lead to decrease R&D cost and faster development of drugs.